Connection

Karin Klingel to Biomarkers

Back to Details
This is a "connection" page, showing publications Karin Klingel has written about Biomarkers.
Karin Klingel
Connection Strength
0.052
Biomarkers
  1. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020 08; 106(15):1127-1131.
    View in: PubMed
    Score: 0.010
  2. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018 11; 77(11):1590-1598.
    View in: PubMed
    Score: 0.009
  3. MD-2 is a new predictive biomarker in dilated cardiomyopathy and exerts direct effects in isolated cardiomyocytes. Int J Cardiol. 2018 Nov 01; 270:278-286.
    View in: PubMed
    Score: 0.009
  4. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017 09 14; 38(35):2649-2662.
    View in: PubMed
    Score: 0.008
  5. Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis. J Immunol Res. 2017; 2017:6590609.
    View in: PubMed
    Score: 0.008
  6. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker. Circ Heart Fail. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.